Optimal therapy and management of endometrial cancer
- 1 February 2003
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 3 (1) , 37-47
- https://doi.org/10.1586/14737140.3.1.37
Abstract
Carcinoma of the endometrium is the most common malignancy of the female genital tract. Fortunately, this neoplasm presents with abnormal clinical symptoms in its early stages. The majority of cases will be detected at a curable stage when the neoplasm is still confined to the uterus. Given this fact, surgical removal of the involved organ remains the cornerstone of treatment for this disease. Certain pathologic risk factors for recurrence have been identified and are the basis for which adjuvant therapy is recommended. Controversy in management exists as to the approach and extent of primary surgery as well as the indications for adjuvant therapy. Management of this disease is reviewed.Keywords
This publication has 17 references indexed in Scilit:
- Conservative Management of Stage I Endometrial Carcinoma after Surgical StagingGynecologic Oncology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Stage IVB Endometrial Carcinoma: The Role of Cytoreductive Surgery and Determinants of SurvivalGynecologic Oncology, 2000
- Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter StudyGynecologic Oncology, 2000
- Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignanciesPublished by Wolters Kluwer Health ,2000
- A Comparison of Treatment Strategies for Endometrial Adenocarcinoma: Analysis of Financial ImpactGynecologic Oncology, 1999
- Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysisGastroenterology, 1996
- Treatment of Recurrent Adenocarcinoma of the Endometrium with Pelvic ExenterationGynecologic Oncology, 1996
- Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer PatientsGynecologic Oncology, 1994
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989